Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for Delirium in Critically Ill Children
NCT03572257Phase 3Withdrawn
- Sponsor
- Medical College of Wisconsin
- Start
- Apr 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in delirium, sponsored by Medical College of Wisconsin. Planned start Apr 2019; status: withdrawn.
02
Drugs
quetiapine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT03572257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03572257.